Chronic cardiac rehabilitation is a comprehensive and structured program designed to improve the health and well-being of individuals with chronic heart conditions. Tailored to the specific needs of patients with ongoing cardiac issues, this rehabilitation process focuses on enhancing cardiovascular fitness, managing symptoms, and promoting a heart-healthy lifestyle. Typically conducted under the supervision of healthcare professionals such as physiotherapists, exercise physiologists, and nurses, chronic cardiac rehabilitation includes a combination of exercise training, education, and counseling. Patients engage in carefully monitored physical activities to strengthen their heart muscles, improve endurance, and enhance overall cardiovascular function. Educational components cover topics such as heart-healthy nutrition, stress management, medication adherence, and risk factor modification. This holistic approach aims to empower individuals with chronic cardiac conditions to lead active and fulfilling lives while minimizing the risk of future cardiovascular events. Chronic cardiac rehabilitation plays a crucial role in not only managing existing heart conditions but also in preventing further complications, ultimately contributing to a higher quality of life for those undergoing the program.
Title : Pharmacological advancement in pulmonary arterial hypertension treatment - Contribution of treprostinil dry-powder formulation
Miroslav Radenkovic, University of Belgrade, Serbia
Title : Historical evolution from OPCAB to MIDCAB to mini OPCAB surgical technique and results
Federico Benetti, Benetti Foundation, Argentina
Title : Personalized and Precision Medicine (PPM) and PPN-guided cardiology practice as a unique model via translational applications and upgraded business modeling to secure human healthcare, wellness and biosafety
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Antibodies with functionality as a new generation of translational tools designed to monitor autoimmune myocarditis at clinical and subclinical stages
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation